Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
30.0%
% of FTXH's 51 holdings also in IHE
41.7%
% of IHE's 37 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 8.1% | 24.4% | 8.1% |
|
PFIZER INC | 7.1% | 4.3% | 4.3% |
|
MERCK & CO. INC. | 7.1% | 4.2% | 4.2% |
|
BRISTOL-MYERS SQUIBB CO | 7.0% | 4.1% | 4.1% |
|
ELI LILLY & CO | 3.9% | 25.8% | 3.9% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to IHE
|
ABBVIE INC | 7.0% |
|
GILEAD SCIENCES INC | 3.9% |
|
AMGEN INC | 3.8% |
|
UNITED THERAPEUTICS CORP | 3.8% |
|
BIOGEN IDEC INC | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.4% |
|
MERCK & CO. INC. | 2.9% |
|
BRISTOL-MYERS SQUIBB CO | 2.8% |
|
PFIZER INC | 2.7% |
|
EXELIXIS INC | 2.1% |
FTXH Underweight Relative to IHE
|
ELI LILLY & CO | -21.9% |
|
JOHNSON & JOHNSON | -16.3% |
|
ROYALTY PHARMA PLC CLASS A | -5.0% |
|
CORCEPT THERAPEUTICS INC | -2.1% |
|
AXSOME THERAPEUTICS, INC. | -1.5% |
|
PRESTIGE BRANDS HOLDINGS INC | -1.0% |
|
LIGAND PHARMACEUTICALS-CL B | -0.9% |
|
ZOETIS INC | -0.9% |
|
TARSUS PHARMACEUTICALS, INC. | -0.8% |
|
SUPERNUS PHARMACEUTICALS INC | -0.8% |